OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
暂无分享,去创建一个
K. Kalunian | B. Kaffenberger | S. Navarra | R. Furie | V. Werth | C. Barbey | N. Franchimont | C. Musselli | J. Romero-Diaz | G. Radunović | R. Furie | F. Nyberg | A. Meyers | S. Sheikh | R. van Vollenhoven | F. Gaudreault | V. Werth | R. V. Vollenhoven | S. Sheikh | H. Carroll | X. Huang | J. Romero-Díaz